Kothari Fermentation & Biochem Ltd.

Kothari Fermentation & Biochem Ltd.

BBSE:KFBL
40.25
INR
+0.24
(+0.60%)
-1.38EPS
670.95MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
33.75
42.89
51.45
52.73
58.46
64.13
64.49
63.7
64.68
73.52
69.69
71.47
74.55
77.59
Basic EPS, GAAP
0.25
0.57
1.26
2.14
3.56
5.81
5.11
3.2
0.2
0.13
-3.27
0.54
-1.99
-1.38
Free Cash Flow per Basic Share
0.8
0.06
-2.66
-0.36
2.67
-3.68
-6
-1.03
-2.3
1.9
0.99
4.67
-0.57
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
18.72
19.25
20.51
22.61
26.18
32.02
37.03
40.19
40.38
40.56
37.27
37.71
35.97
- -
Tangible Book Value per Share
18.72
19.25
20.51
22.61
26.18
32.02
37.03
40.19
40.38
40.56
37.27
37.71
35.97
- -
Basic Weighted Avg Shares
15
15
15
15
15
15
15
15
15
15
15
15
15
15
Sales/Revenue/Turnover
506
643
772
791
877
962
967
956
970
1,103
1,045
1,072
1,118
1,188
Operating Margin (%)
3.5
5.26
5.35
8.07
10.02
14.9
11.13
9.69
4.84
2.99
-0.37
5.12
0.18
0.42
Depreciation Expense
19
17
20
26
31
37
44
52
58
58
56
64
70
70
Net Income, GAAP
4
9
19
32
53
87
77
48
3
2
-49
8
-30
-21
Effective Tax Rate (%)
31.62
38.54
33.67
34.1
25.74
30.29
29.55
16.89
79.71
33.55
- -
58.22
- -
- -
Profit Margin (%)
0.75
1.34
2.45
4.06
6.08
9.06
7.93
5.03
0.32
0.17
-4.7
0.76
-2.67
-1.78
Working Capital
24
39
-29
-27
3
20
40
7
9
38
-4
25
162
- -
LT Debt
37
44
62
95
104
158
200
238
281
282
286
267
428
- -
Total Equity
281
289
308
339
393
480
555
603
606
608
559
566
539
- -
Return on Invested Capital (%)
0.99
2.17
4.28
6.27
11.94
15.41
11.48
8.09
0.88
1.99
- -
2.26
- -
- -
Return on Capital (%)
3.14
4.11
6.3
8.33
12.04
15.51
11.45
7.65
0.86
1.95
- -
2.25
- -
- -
Return on Common Equity (%)
1.36
3.02
6.33
9.94
14.58
19.96
14.81
8.3
0.51
0.32
-8.41
1.44
-5.41
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
51
- -
LT Borrowings
- -
428
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
15
15
Market Capitalization
653
510
671

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
341
- -
Cash, Cash Equivalents & STI
- -
12
- -
Accounts Receivable, Net
- -
63
- -
Inventories
- -
233
- -
Total Current Liabilities
- -
179
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
51
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.19%
-2.13%
-4.64%
Free Cash Flow
-102.67%
30.76%
-112.12%
Net Income, GAAP
-322.84%
-675.72%
-469.09%
Sales/Revenue/Turnover
3.92%
3.37%
4.3%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
264
252
305
322
1,072
2026
238
240
319
325
1,118
2027
304
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.73
-1.17
0.27
0.7
0.54
2026
-0.75
-2.05
-0.25
0.85
-1.99
2027
0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Pramod Kumar Kothari
Full Time Employees
208
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
16, Community Centre New Delhi DE India 110017
IPO Date
Oct 12, 1992
Business
Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives primarily for bakeries, distilleries, animal feeds, food processing, pharmaceuticals, and biotechnology applications in India and for export markets. The company produces fresh compressed yeast, active dried yeast, instant dried yeast including Super Fast Instant Yeast and Four Seasons brands, inactive dried yeast, live yeast, distiller dried yeast such as Alcomax Distiller’s Instant Yeast, yeast extract powder, yeast autolyzate extract powder, oligo saccharides, cell walls, and molasses dried yeast under brands including Kothari SUNRISE and KF; these products serve alcohol fermentation, food, veterinary, and pharmaceutical sectors from its manufacturing facility in Sikandrabad, Uttar Pradesh, with an installed capacity of 25,000 metric tons annually. Founded in 1990 and headquartered in New Delhi, India, the company maintains ISO 22000:2018 and KOSHER certifications while offering private labelling services. Recent developments include a bulk sales order for 100 MT per month of Alcomax Instant Dry Yeast to KRS Multiproducts LLP valued at Rs 20-25 crore over six months, a manufacturing agreement with Israel-based NextFerm Technologies for ProteVin vegan protein production, a joint venture memorandum with NextFerm for yeast extract and cell wall distribution, management changes such as the appointment of Shivani Kamra as Company Secretary in April 2025 and re-appointment of Whole Time Director Siddhant Kothari, and receipt of additional board appointments including Varun Kumar as Independent Director.